The Enterprise Value as of December 2025 (TTM) for LB Pharmaceuticals Inc Common Stock (LBRX) is 467.73M

According to LB Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 467.73M. This represents a change of 4.13% compared to the average of 11.05M of the last 4 quarters.

LB Pharmaceuticals Inc Common Stock (LBRX) Historical Enterprise Value (quarterly & annually)

How has LBRX Enterprise Value performed in the past?

The mean historical Enterprise Value of LB Pharmaceuticals Inc Common Stock over the last ten years is 50.74M. The current 467.73M Enterprise Value has changed 92.07% with respect to the historical average. Over the past ten years (40 quarters), LBRX's Enterprise Value was at its highest in in the March 2024 quarter at 43.62M. The Enterprise Value was at its lowest in in the June 2025 quarter at -10464000.00.

LB Pharmaceuticals Inc Common Stock (LBRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of LB Pharmaceuticals Inc Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LB Pharmaceuticals Inc Common Stock (LBRX) Average Enterprise Value

How has LBRX Enterprise Value performed in the past?

The current Enterprise Value of LB Pharmaceuticals Inc Common Stock (LBRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

LB Pharmaceuticals Inc Common Stock (LBRX) Enterprise Value vs. Peers

How is LBRX’s Enterprise Value compared to its peers?

LB Pharmaceuticals Inc Common Stock’s Enterprise Value is greater than Rocket Pharmaceuticals, Inc. (319.22M), greater than Aura Biosciences, Inc. (320.33M), greater than Annexon, Inc. (432.32M), greater than Solid Biosciences Inc. (421.79M), greater than Larimar Therapeutics, Inc. (299.00M), greater than Altimmune, Inc. (407.41M), greater than Autolus Therapeutics plc (358.55M), greater than DBV Technologies S.A. (353.89M), less than Design Therapeutics, Inc. (540.75M), greater than Korro Bio, Inc. (74.88M),

Build a custom stock screener for LB Pharmaceuticals Inc Common Stock (LBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LB Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LB Pharmaceuticals Inc Common Stock (LBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LB Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.